publication venue for
- COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular disease.. 34. 2023
- Cyclotron vs generator-produced 68Ga PSMA: a single-institution, prospective clinical trial.. 28. 2022
- Advances in PSMA theranostics.. 22. 2022
- 68Ga-PSMA-HBED-CC PET/MRI is superior to multiparametric magnetic resonance imaging in men with biochemical recurrent prostate cancer: A prospective single-institutional study.. 15. 2021
- Vanucizumab mode of action: Serial biomarkers in plasma, tumor, and skin-wound-healing biopsies.. 14. 2020
- Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology.. 14. 2020
- VCAM-1 Upregulation Contributes to Insensitivity of Vemurafenib in BRAF-Mutant Thyroid Cancer.. 13. 2020
- B7-H3 as a Prognostic Biomarker and Therapeutic Target in Pediatric central nervous system Tumors.. 13. 2019
- Combined Metabolomics and Genome-Wide Transcriptomics Analyses Show Multiple HIF1α-Induced Changes in Lipid Metabolism in Early Stage Clear Cell Renal Cell Carcinoma.. 13. 2019
- Quadruple Negative Breast Cancers (QNBC) Demonstrate Subtype Consistency among Primary and Recurrent or Metastatic Breast Cancer.. 12. 2018
- Dual Inhibition of PI3K/AKT and MEK/ERK Pathways Induces Synergistic Antitumor Effects in Diffuse Intrinsic Pontine Glioma Cells.. 10. 2017
- miR-1207-3p Is a Novel Prognostic Biomarker of Prostate Cancer.. 9. 2016
- A Preclinical Model of Inflammatory Breast Cancer to Study the Involvement of CXCR4 and ACKR3 in the Metastatic Process.. 8. 2015
- Mutational Analysis of Circulating Tumor Cells Using a Novel Microfluidic Collection Device and qPCR Assay.. 6. 2013
- Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen.. 6. 2013
- Mapping Tumor Hypoxia In Vivo Using Pattern Recognition of Dynamic Contrast-enhanced MRI Data.. 5. 2012
- A tolerability and pharmacokinetic study of adjuvant erlotinib and capecitabine with concurrent radiation in resected pancreatic cancer.. 3. 2010
- Computed tomography assessment of response to therapy: tumor volume change measurement, truth data, and error.. 2. 2009